Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hans M.G. Princen"'
Autor:
André Rex, Vincent Prinz, Hans M.G. Princen, Paul Fischer, Matthias Endres, Frieder Schlunk, Dieter Lütjohann, Ulrich Laufs, Marco Foddis
Publikováno v:
Behavioural brain research 396, 112875-(2021). doi:10.1016/j.bbr.2020.112875
Behavioral Brain Research, 396
Behavioral Brain Research, 396
Monoclonal anti-proprotein convertase subtilisin/kexin type 9 (PSCK9) neutralizing antibodies effectively lower plasma cholesterol levels and decrease cardiovascular events but also raised some concern that cognitive function could worsen as a side e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57f54470c79c01128abda419148f08a
Publikováno v:
Toxicology Reports, Vol 3, Iss, Pp 306-309 (2016)
Toxicology Reports
Toxicology Reports
A recent article in Toxicology Reports by [26] reported increased plasma cholesterol levels (primarily as HDL) in C57BL/6 (male and female) and BALB/c (male only) mice given high fat (Westernized) diet which also contained PFOA. The authors concluded
Autor:
Louis H. Cohen, Kazuo Suzuki, Thomas Kelder, Hans M.G. Princen, Elsbet J. Pieterman, Hiroshi Shimada, Louis M. Havekes, Kanami Sugimoto-Kawabata, Kaoru Sakai, Anita M. van den Hoek
Publikováno v:
Journal of Lipid Research, Vol 54, Iss 5, Pp 1255-1264 (2013)
Journal of Lipid Research, 5, 54, 1255-1264
Journal of Lipid Research, 54(5), 1255-1264
Journal of Lipid Research, 5, 54, 1255-1264
Journal of Lipid Research, 54(5), 1255-1264
Bile acid sequestrants (BASs) are cholesterollowering drugs that also affect hyperglycemia. The mechanism by which BASs exert these and other metabolic effects beyond cholesterol lowering remains poorly understood. The present study aimed to investig
Autor:
Hans M.G. Princen, Patrick C.N. Rensen, Willeke de Haan, Menno Hoekstra, Marit Westerterp, Johannes A. Romijn, Louis M. Havekes, J. Wouter Jukema, Caroline C. van der Hoogt, Geesje M. Dallinga-Thie
Publikováno v:
Journal of Lipid Research, Vol 48, Iss 8, Pp 1763-1771 (2007)
Journal of lipid research, 48(8), 1763-1771. American Society for Biochemistry and Molecular Biology Inc.
Journal of lipid research, 48(8), 1763-1771. American Society for Biochemistry and Molecular Biology Inc.
In addition to efficiently decreasing VLDL-triglycerides (TGs), fenofibrate increases HDL-cholesterol levels in humans. We investigated whether the fenofibrate-induced increase in HDL-cholesterol is dependent on the expression of the cholesteryl este